High-Intensity Laser Therapy for Eosinophilic Fasciitis

NCT05915585 | Unknown

• 1 other identifier: 010/012023
• Study Type: interventional
• Target: 1
• Locations: 1 country
• Sites: 1

Brief Summary

Eosinophilic fasciitis (EF) is a rare musculoskeletal disorder characterized by inflammation and thickening of the fascia, leading to pain, stiffness, and functional impairment. Conventional treatment options include immunosuppressive medications, corticosteroids, and physical therapy. This case report will describe use of high-intensity laser therapy (HILT) using the Mectronic Exand MY high-intensity laser system in a patient with EF, highlighting its potential as an alternative or adjunct treatment option.

Conditions

Eosinophilic Fasciitis

Outcome Measures

Primary Outcomes (4)

• Pain intensity via Numeric pain rating scale

  Changes in pain intensity at baseline and 4 weeks

• Functional outcomes via Disabilities of the Arm, Shoulder and Hand questionnaire (DASH)

  Changes in DASH at baseline and 4 weeks

• Quality of life via Short Form-36 Health Survey

  Changes in Short Form-36 Health Survey at baseline and 4 weeks

• Adverse event

  adverse events are recorded by the patient and therapist

  4 Weeks

Study Arms (1)

High-Intensity Laser Therapy (HILT)

EXPERIMENTAL

Device: High-Intensity Laser Therapy

Interventions

High-Intensity Laser Therapy DEVICE

The patient will receive HILT using the Mectronic Exand MY high-intensity laser system with the following parameters: Wavelength: 1064 nm (near-infrared) Power: 12 W Energy density: 8 J/cm² Pulse duration: 200 µs Treatment duration: 10 minutes Frequency: 3 sessions per week for 4 weeks Total energy delivered: 96 J per treatment session

High-Intensity Laser Therapy (HILT)

Eligibility Criteria

• Sex: female
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients diagnosed with Eosinophilic fasciitis.

You may not qualify if:

• a diagnosis unrelated to Eosinophilic fasciitis

Sponsors & Collaborators

• Ahram Canadian University: lead

Study Sites (1)

Outpatient clinic of faculty of physical therapy, Ahram Canadian University

Al Ḩayy Ath Thāmin, Giza Governorate, 3221405, Egypt

RECRUITING

MeSH Terms

Conditions

Eosinophilic Fasciitis

Study Officials

• Amal Fawzy, Ph.d

  Faculty of Physical Therapy, Ahram Canadian University

  STUDY DIRECTOR

Central Study Contacts

Mohamed M ElMeligie, Ph.d

CONTACT

+201064442032; mohamed.elmeligie@acu.edu.eg

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer of Physical Therapy and Director of Electromyography Lab

Model Details: Single participant case study

Study Record Dates

• First Submitted: June 14, 2023
• First Posted: June 23, 2023
• Study Start: June 18, 2023
• Primary Completion: July 19, 2023
• Study Completion: July 20, 2023
• Last Updated: June 23, 2023

Record last verified: 2023-06

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)